(Q51403316)
Statements
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study (English)
Yok-Lam Kwong
Won Seog Kim
Yoshinobu Maeda
Chizuko Hashimoto
Fumihiro Ishida
Yasushi Isobe
Eisaburo Sueoka
Junji Suzumiya
Takao Kodama
Rie Hyo
Shigeo Nakamura
11 October 2011